News und Analysen
Rand Capital Announces $0.29 per Share Cash Dividend for Third Quarter 2025
Rand Capital Corporation (Nasdaq: RAND) (“Rand” or the “Company”), a business development company providing alternative financing for lower middle market companies, announced today that its Board
Rand Capital Announces Second Quarter 2025 Financial Results Conference Call and Webcast
Rand Capital Corporation (Nasdaq: RAND) (“Rand” or the “Company”), a business development company providing alternative financing for lower middle market companies, announced that it plans to
Westwater Resources Supports U.S. Department of Commerce Anti-Dumping Ruling on Chinese Graphite
Westwater Resources, Inc. (NYSE American: WWR), an energy technology and battery-grade natural graphite company (“Westwater” or the “Company”), announced today its support of the U.S. Department of
Vistagen Honored for Outstanding Workplace Culture and Mental Health Leadership
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product
Mannatech Announces Promotion of Peter Griscom to Chief Operating Officer
Mannatech, Incorporated (NASDAQ: MTEX) announces the promotion of Peter Griscom to Chief Operating Officer of Mannatech Incorporated (the "Company") effective July 1, 2025.
Peter Griscom brings
Vistagen Appoints Elissa Cote as Chief Corporate Development Officer
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product
Vistagen Reports Fiscal Year 2025 Financial Results and Provides Corporate Update
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product
Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product
Mannatech Announces Results of Annual Shareholders’ Meeting
Mannatech, Incorporated (Nasdaq: MTEX) ("Mannatech"), a global health and wellness company committed to transforming lives to make a better world, announced that its shareholders passed all
Vistagen on Track to Deliver Topline Data From Fasedienol PALISADE-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product
Westwater Resources Supports U.S. Department of Commerce Decision on Chinese Graphite Anode Material
Westwater Resources, Inc. (NYSE American: WWR), an energy technology and battery-grade natural graphite company (“Westwater” or the “Company”), announced today its support of the U.S. Department of
Vistagen to Present at the Jefferies 2025 Global Life Sciences Conference New York
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product
Westwater Resources Announces Successful Patent Application for the Kellyton Graphite Plant
Westwater Resources, Inc. (NYSE American: WWR) an energy technology and battery-grade natural graphite development company, today announced it received a Notice of Allowance from the U.S. Patent
Vistagen to Present at the 2025 American Society of Clinical Psychopharmacology Conference
Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product
Mannatech Premieres Powerful New Documentary on Marathon Legend Steve Edwards
Global health and wellness innovator Mannatech is proud to premiere Steve Edwards: The Long Run, an 11-minute short documentary chronicling the unbelievable true story of Steve Edwards—an everyday
Westwater Resources Announces Investor Conference Call on May 27, 2025
Westwater Resources, Inc. (NYSE American: WWR) an energy technology and battery-grade natural graphite development company, today announced its next investor conference call will be held on May 27
Westwater Resources Announces First Quarter Business Updates and Date of Investor Call
Westwater Resources, Inc. (NYSE American: WWR), an energy technology and battery-grade natural graphite development company (“Westwater” or the “Company”), is pleased to announce its results for
Mannatech Reports Financial Results for First Quarter 2025
Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for
Westwater Resources Receives Letter of Interest from US EXIM Bank for the Kellyton Graphite Plant
Westwater Resources, Inc. (NYSE American: WWR), an energy technology and battery-grade natural graphite company (“Westwater” or the “Company”), announced today that it has received a letter of
Rand Capital Reports Increase in Net Investment Income for First Quarter 2025
Rand Capital Corporation (Nasdaq: RAND) (“Rand” or the “Company”), a business development company providing alternative financing for lower middle market companies, announced its results for the
Rand Capital Announces $0.29 per Share Cash Dividend for Second Quarter 2025
Rand Capital Corporation (Nasdaq: RAND) (“Rand” or the “Company”), a business development company providing alternative financing for lower middle market companies, announced today that its Board
Rand Capital Announces First Quarter 2025 Financial Results Conference Call and Webcast
Rand Capital Corporation (Nasdaq: RAND) (“Rand” or the “Company”), a business development company providing alternative financing for lower middle market companies, announced that it plans to
Vistagen Presents New Research on the Impact of Social Anxiety Disorder at The Anxiety and Depression Association 2025 Conference
Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product
Westwater Resources Sees Increased Demand for Kellyton Product After Implementation of Global Tariffs
Westwater Resources, Inc. (NYSE American: WWR), an energy technology and battery-grade natural graphite company (“Westwater” or the “Company”), announced today that it is experiencing increased
Form 8.3 - The Vanguard Group, Inc.: PureTech Health plc
